MA27631A1 - Procede de culture cellulaire n'utilisant pas de composants d'origine animale - Google Patents
Procede de culture cellulaire n'utilisant pas de composants d'origine animaleInfo
- Publication number
- MA27631A1 MA27631A1 MA28488A MA28488A MA27631A1 MA 27631 A1 MA27631 A1 MA 27631A1 MA 28488 A MA28488 A MA 28488A MA 28488 A MA28488 A MA 28488A MA 27631 A1 MA27631 A1 MA 27631A1
- Authority
- MA
- Morocco
- Prior art keywords
- cell culture
- cells
- animal
- relates
- animal origin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCÉDÉ DE CULTURE CELLULAIRE N'UTILISANT PAS DE COMPOSANTS D'ORIGINE ANIMALE La présente invention concerne un procédé de culture de cellules animales, de préférence des cellules diploïdes humaines ancrage-dépendantes, en absence de composants exogènes d'origine animale primaire, et un milieu de culture cellulaire essentiellement exempt de composants exogènes d'origine animale primaire approprié pour réaliser ledit procédé. En particulier, l'invention concerne un milieu de culture cellulaire qui comprend au moins un, et de manières davantage préférées plusieurs facteurs de croissance exogènes n'ayant pas une origine animale. La présente invention concerne également un procédé destiné à la culture de cellules animales, de préférence des cellules diploïdes humaines ancrage-dépendantes, dans un milieu selon l'invention, impliquant l'utilisation d'un substitut de trypsine d'origine non-animale pour le repiquage des cellules. L'invention concerne en outre un procédé de production de virus, de vaccins viraux et équivalent. (Figure 1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0304799.0A GB0304799D0 (en) | 2003-03-03 | 2003-03-03 | Novel method |
Publications (1)
Publication Number | Publication Date |
---|---|
MA27631A1 true MA27631A1 (fr) | 2005-11-01 |
Family
ID=9953995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA28488A MA27631A1 (fr) | 2003-03-03 | 2005-09-09 | Procede de culture cellulaire n'utilisant pas de composants d'origine animale |
Country Status (17)
Country | Link |
---|---|
US (1) | US8034617B2 (fr) |
EP (3) | EP2186885A1 (fr) |
JP (2) | JP4787739B2 (fr) |
KR (1) | KR101242090B1 (fr) |
CN (2) | CN101200705A (fr) |
AU (1) | AU2004217807B2 (fr) |
BR (1) | BRPI0407636A (fr) |
CA (1) | CA2517327A1 (fr) |
CO (1) | CO5601047A2 (fr) |
GB (1) | GB0304799D0 (fr) |
IS (1) | IS7992A (fr) |
MA (1) | MA27631A1 (fr) |
MX (1) | MXPA05009096A (fr) |
NO (1) | NO20054124L (fr) |
NZ (1) | NZ541908A (fr) |
RU (1) | RU2369634C2 (fr) |
WO (1) | WO2004078955A1 (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2335650B1 (fr) | 2003-12-11 | 2012-10-03 | Isto Technologies Inc. | Système chondral particulier |
US8221969B2 (en) | 2004-04-19 | 2012-07-17 | Sanyo Chemical Industries, Ltd. | Method of producing virus |
EP1812557A4 (fr) * | 2004-10-29 | 2009-11-04 | Centocor Ortho Biotech Inc | Compositions de milieux chimiquement definis |
WO2006095431A1 (fr) * | 2005-03-10 | 2006-09-14 | Kyoritsu Seiyaku Corporation | Lignee cellulaire cultivable sans composant derive d’un animal, procede destine a l’etablir, procede de production de virus utilisant la lignee cellulaire et procede de production de vaccins |
AU2006254217A1 (en) * | 2005-06-03 | 2006-12-07 | Biovitrum Ab (Publ) | Process for cultivating animal cells comprising the feeding of plant-derived peptones |
US8480757B2 (en) | 2005-08-26 | 2013-07-09 | Zimmer, Inc. | Implants and methods for repair, replacement and treatment of disease |
EP1764117A1 (fr) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implant pour la réparation de défauts cartilagineux et son procédé de préparation |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
AU2008240191B2 (en) | 2007-04-12 | 2013-09-19 | Zimmer, Inc. | Compositions and methods for tissue repair |
FI20075417A0 (fi) * | 2007-06-05 | 2007-06-05 | Marjo-Riitta Suuronen | Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen |
EP2250251B1 (fr) | 2008-01-09 | 2017-11-22 | Sartorius Stedim Cellca GmbH | Additif amélioré de milieu de culture et son procédé d'utilisation |
NZ700477A (en) | 2009-02-17 | 2016-04-29 | Glaxosmithkline Biolog Sa | Inactivated dengue virus vaccine with aluminium-free adjuvant |
KR101828623B1 (ko) | 2010-04-26 | 2018-02-12 | 노파르티스 아게 | 개선된 세포 배양 배지 |
CN101831415B (zh) * | 2010-05-12 | 2012-05-30 | 江苏博立生物制品有限公司 | 一种提高糖化酶发酵水平的方法 |
KR102351944B1 (ko) * | 2011-02-28 | 2022-01-18 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 세포 배양 시스템 |
PT2788009T (pt) | 2011-12-08 | 2016-08-31 | Yeda Res & Dev | Células pulmonares fetais de mamíferos e uso terapêutico das mesmas |
US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
JP6041199B2 (ja) * | 2012-09-14 | 2016-12-07 | 国立大学法人大阪大学 | 三次元細胞培養体の製造方法 |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
EP4026563A1 (fr) | 2015-06-18 | 2022-07-13 | Yeda Research and Development Co. Ltd | Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu |
US10004795B2 (en) * | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
BE1024160A9 (fr) | 2015-12-22 | 2017-12-06 | Glaxosmithkline Biologicals Sa | Formulation immunogène |
CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
CN105779376B (zh) * | 2016-03-24 | 2019-08-30 | 友康恒业生物科技(北京)有限公司 | 一种流感病毒分离无血清培养基及其用途和制备 |
CN105695393B (zh) * | 2016-03-24 | 2019-09-10 | 友康恒业生物科技(北京)有限公司 | 一种mdck细胞无血清培养基及其用途和制备 |
KR101925079B1 (ko) * | 2017-05-24 | 2018-12-04 | 가천대학교 산학협력단 | Dna 정제-증폭을 위한 통합형 마이크로 디바이스 및 이를 이용한 dna 정제-증폭 방법 |
CN107432931B (zh) * | 2017-08-03 | 2018-04-13 | 长春祈健生物制品有限公司 | 一种微载体培养水痘病毒制备疫苗的方法 |
BR112021014116A2 (pt) * | 2019-01-17 | 2021-09-21 | Boehringer Ingelheim Animal Health USA Inc. | Meio sem soro para produção de vacinas aviárias e seus usos |
CN113373107B (zh) * | 2021-01-29 | 2022-12-30 | 上海生物制品研究所有限责任公司 | 一种大规模制备传代鸡胚细胞生产病毒的方法 |
WO2024039216A1 (fr) * | 2022-08-19 | 2024-02-22 | 셀미트주식회사 | Procédé de culture de cellules animales ou d'une lignée de cellules animales |
CN115627255B (zh) * | 2022-12-01 | 2023-04-07 | 天信和(苏州)生物科技有限公司 | 一种采用低血清培养基培养人二倍体细胞的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2018228C (fr) * | 1989-06-05 | 1996-02-27 | Nancy L. Parenteau | Systemes et milieu de culture cellulaire |
GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
DE4115722A1 (de) | 1991-05-14 | 1992-11-19 | Boehringer Mannheim Gmbh | Serumfreies medium zur kultivierung von saeugerzellen |
DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
JP3523646B2 (ja) | 1992-09-18 | 2004-04-26 | スミスクライン・ビーチヤム・バイオロジカルズ・エス・エイ | A型肝炎ワクチン |
CN1088984A (zh) * | 1993-11-11 | 1994-07-06 | 江西省医学科学研究所 | 一种用于造血祖细胞培养的无血清培养基 |
HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
ES2378409T3 (es) | 1994-11-10 | 2012-04-12 | Baxter Healthcare S.A. | Método para producir sustancias biológicas en cultivo sin proteínas |
WO1998000521A1 (fr) * | 1996-06-28 | 1998-01-08 | The Green Cross Corporation | Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives |
WO1998004680A1 (fr) * | 1996-07-26 | 1998-02-05 | University Of Manitoba | Milieu ne contenant pas de serum, destine a la culture de cellules mammaliennes dependantes d'un support |
US6103529A (en) * | 1996-10-10 | 2000-08-15 | Life Technologies, Inc. | Animal cell culture media comprising peptides derived from rice |
WO1998059035A2 (fr) | 1997-06-25 | 1998-12-30 | The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health | Milieu de croissance cellulaire ne contenant pas de serum |
US6656719B1 (en) * | 1997-10-27 | 2003-12-02 | Merck & Co., Inc. | Serum-free, low-protein media for rotavirus vaccine production |
FR2775983B1 (fr) | 1998-03-13 | 2000-11-10 | Pasteur Merieux Serums Vacc | Milieu et procede de propagation et de multiplication virales |
WO1999057246A1 (fr) * | 1998-05-01 | 1999-11-11 | Life Technologies, Inc. | Milieux de culture de cellules animales comprenant des elements nutritifs derives des vegetaux |
US6406909B1 (en) | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
US6623959B2 (en) * | 2001-06-13 | 2003-09-23 | Ethicon, Inc. | Devices and methods for cell harvesting |
-
2003
- 2003-03-03 GB GBGB0304799.0A patent/GB0304799D0/en not_active Ceased
-
2004
- 2004-03-01 BR BRPI0407636-2A patent/BRPI0407636A/pt not_active IP Right Cessation
- 2004-03-01 EP EP10151350A patent/EP2186885A1/fr not_active Withdrawn
- 2004-03-01 AU AU2004217807A patent/AU2004217807B2/en not_active Ceased
- 2004-03-01 JP JP2006504501A patent/JP4787739B2/ja not_active Expired - Fee Related
- 2004-03-01 WO PCT/EP2004/002067 patent/WO2004078955A1/fr active Application Filing
- 2004-03-01 EP EP04715891A patent/EP1599580A1/fr not_active Ceased
- 2004-03-01 US US10/547,804 patent/US8034617B2/en not_active Expired - Fee Related
- 2004-03-01 MX MXPA05009096A patent/MXPA05009096A/es active IP Right Grant
- 2004-03-01 RU RU2005125606/13A patent/RU2369634C2/ru not_active IP Right Cessation
- 2004-03-01 EP EP10151351A patent/EP2192175A1/fr not_active Ceased
- 2004-03-01 CN CNA2007101866779A patent/CN101200705A/zh active Pending
- 2004-03-01 CN CN2004800058488A patent/CN1756837B/zh not_active Expired - Fee Related
- 2004-03-01 CA CA002517327A patent/CA2517327A1/fr not_active Abandoned
- 2004-03-01 KR KR1020057016385A patent/KR101242090B1/ko not_active IP Right Cessation
- 2004-03-01 NZ NZ541908A patent/NZ541908A/en unknown
-
2005
- 2005-08-18 IS IS7992A patent/IS7992A/is unknown
- 2005-08-31 CO CO05087280A patent/CO5601047A2/es not_active Application Discontinuation
- 2005-09-05 NO NO20054124A patent/NO20054124L/no not_active Application Discontinuation
- 2005-09-09 MA MA28488A patent/MA27631A1/fr unknown
-
2010
- 2010-07-12 JP JP2010157682A patent/JP2010273683A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IS7992A (is) | 2005-08-18 |
CN1756837B (zh) | 2010-05-26 |
CO5601047A2 (es) | 2006-01-31 |
CN1756837A (zh) | 2006-04-05 |
MXPA05009096A (es) | 2005-10-19 |
CA2517327A1 (fr) | 2004-09-16 |
EP2192175A1 (fr) | 2010-06-02 |
RU2369634C2 (ru) | 2009-10-10 |
EP2186885A1 (fr) | 2010-05-19 |
NO20054124D0 (no) | 2005-09-05 |
NO20054124L (no) | 2005-09-27 |
JP4787739B2 (ja) | 2011-10-05 |
NZ541908A (en) | 2008-04-30 |
CN101200705A (zh) | 2008-06-18 |
US8034617B2 (en) | 2011-10-11 |
GB0304799D0 (en) | 2003-04-09 |
BRPI0407636A (pt) | 2006-02-21 |
US20060183224A1 (en) | 2006-08-17 |
JP2010273683A (ja) | 2010-12-09 |
WO2004078955A1 (fr) | 2004-09-16 |
AU2004217807A1 (en) | 2004-09-16 |
KR101242090B1 (ko) | 2013-03-08 |
RU2005125606A (ru) | 2006-03-10 |
KR20050105509A (ko) | 2005-11-04 |
JP2006519023A (ja) | 2006-08-24 |
EP1599580A1 (fr) | 2005-11-30 |
AU2004217807B2 (en) | 2009-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27631A1 (fr) | Procede de culture cellulaire n'utilisant pas de composants d'origine animale | |
MX2007005132A (es) | Medios libres de proteina animal para cultivo de celulas. | |
DK0904351T3 (da) | Dyreceller og fremgangsmåder til replikationen af influenzavirus | |
DK1651758T3 (da) | Fremgangsmåde tl fremstilling af L-lysin eller L-threonin ved anvendelse af Escherichia bakterier med svækket æblesyreenzymaktivitet | |
NO20022180D0 (no) | Hematopoietisk differensiering av humane embryoniske stamceller | |
WO2007115337A3 (fr) | Ingéniérie tissulaire utilisant des cellules souches embryonnaires humaines | |
GB0706626D0 (en) | Medium and culture of embryonic stem cells | |
WO1999057246A8 (fr) | Milieux de culture de cellules animales comprenant des elements nutritifs derives des vegetaux | |
HK1080507A1 (en) | Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions | |
DE69738806D1 (de) | Tierzellkulturmedium mit pflanzlichen nährstoffen | |
SG150387A1 (en) | Apparatus and methods for amplification of blood stem cell numbers | |
DK0910239T3 (da) | Transformation af bomuldplanter | |
HK1108713A1 (en) | Animal protein free media for cultivation of cells | |
DK1170376T3 (da) | Fremgangsmåde til fremstilling af L-aminosyre eller nukleinsyre ved anvendelse af mikroorganisme | |
TW200636068A (en) | A method of culturing a cell and use of the same | |
RU2012130928A (ru) | Способ культивирования адгезионных клеток | |
CA2437962A1 (fr) | Methode d'extraction d'un virus a partir d'une culture cellulaire | |
AU2003261308A8 (en) | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays | |
EP1739167A4 (fr) | Méthode de production de virus | |
ATE258594T1 (de) | Verfahren zur steigerung des wachstums von pflanzenzellkulturen | |
WO2002102971A3 (fr) | Methodes d'utilisation de cellules souches hematopoietiques cultivees afin d'induire une tolerance immunologique | |
HUP0101081A2 (hu) | Tápközeg és eljárás vírustenyésztésre és szaporításra | |
ATE366803T1 (de) | Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit | |
MA27416A1 (fr) | Cellules pulmonaires du rat des cotonniers pour la culture de virus | |
DK1757312T3 (da) | Frysetørret sammensætning af inaktiveret viruskappe med membranfusionsaktivitet |